Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTapentadol immediate release for the relief of moderate-to-severe acute pain
Expert Opinion in Pharmacotherapy, 10/08/09
Hartrick CT – Tapentadol is a novel, centrally acting analgesic with two mechanisms of action: mu–opioid receptor agonism and norepinephrine reuptake inhibition. It has demonstrated broad analgesic efficacy across multiple pain models. This article reviews the clinical development of tapentadol immediate release (IR), including results from Phase II and III clinical trials that evaluated the efficacy and safety of tapentadol IR in patients with moderate–to–severe acute pain. In clinical studies in patients with moderate–to–severe acute postoperative pain, osteoarthritis pain and/or low back pain, tapentadol IR 50, 75 or 100 mg every 4 – 6 h has demonstrated analgesic efficacy similar to that observed with the mu–opioid receptor agonist oxycodone HCl IR 10 or 15 mg every 4 – 6 h. However, at doses providing comparable analgesic efficacy, tapentadol IR has been associated with significantly lower incidences of nausea and/or vomiting and constipation, and a significantly lower rate of treatment discontinuation compared with oxycodone IR.
Related Articles
Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single molecule
Drugs of Today, 10/19/09
Relevance Score: 70%
"Tapentadol" - A Novel Analgesic
Journal of Anaesthesiology Clinical Pharmacology, 10/05/09
Relevance Score: 66%
Pain among Veterans of Operations Enduring Freedom and Iraqi Freedom: Do Women and Men Differ?
Pain Medicine, 10/13/09
Relevance Score: 49%
Prognosis for patients with chronic low back pain: inception cohort study
British Medical Journal, 10/09/09
Relevance Score: 49%
Corticosteroid Injection Treatment to the Ischiadic Spine Reduced Pain in Women With Long-Lasting Sacral Low Back Pain With Onset During Pregnancy: A Randomized, Double Blind, Controlled Trial
Spine, 10/01/09
Relevance Score: 49%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Cross Talk: A New Method for Peripheral Nerve Stimulation. An Observational Report with Cadaveric Verification
Pain Physician, 11/25/09
Ultrasound-Guided Cryoablation of Genitofemoral Nerve for Chronic Inguinal Pain
Pain Physician, 11/25/09
Evidence-Based Medicine, Systematic Reviews, and Guidelines in Interventional Pain Management: Part 7: Systematic Reviews and Meta-Analyses of Diagnostic Accuracy Studies
Pain Physician, 11/25/09
Sponsor
Article Search
Sponsor